home / stock / sgtx / sgtx news

SGTX News and Press, Sigilon Therapeutics Inc. From 12/18/20

Stock Information
Company Name: Sigilon Therapeutics Inc.
Stock Symbol: SGTX
Market: NASDAQ
Website: sigilon.com
Menu
SGTX SGTX Quote SGTX Short SGTX News SGTX Articles SGTX Message Board
Get SGTX Alerts

News, Short Squeeze, Breakout and More Instantly...
SGTX - 2020 IPO Bubble Just Reached Dot-Com Levels

Expectations are coming in for 2021. Despite the strong recent gains and record valuations, analysts and investors are expecting even more upside based on "the new normal". The IPO market has proven to be an extremely valuable indicator for future returns. Investors are clearly missin...
SGTX - Sigilon Therapeutics' MPS-1 gene therapy an Orphan Drug in U.S.

The FDA grants Orphan Drug designation to Sigilon Therapeutics' (SGTX) SIG-005 for the treatment of mucopolysaccharidosis type I (MPS-1), a rare inherited disorder in which the body cannot metabolized large sugar molecules called glycosaminoglycans due to a deficiency in an enzyme c...

SGTX - Sigilon Therapeutics Receives Orphan Drug Designation for SIG-005 for the Treatment of Mucopolysaccharidosis Type I

CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced that the United States Food and ...

SGTX - Sigilon Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

CAMBRIDGE, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (Nasdaq: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced the closing of its upsized initial pu...
Previous 10 Next 10